Market Research Reports and Industry Reports

Biochips Market by Type (DNA Chip (Genomics, Drug Discovery, Gene Expression) Lab-on-a-chip (IVD & POC, Proteomics), Protein Chips), End user (Academics Institutes, Diagnostics Centers), Fabrication Technology (Microarrays, Microfluidics) - Forecast to 2020

  • DESCRIPTION
  • TABLE OF
    CONTENTS
  • RELATED
    REPORTS
  • SAMPLE REQUEST
  • PURCHASE BY
    SECTION

 Growing Applications of Biochips and Technological Advancements Will Boost the Growth of the Biochips Market
 
 The biochips market is expected to reach USD 17.75 billion by 2020 from USD 7.63 billion in 2015, growing at a CAGR of 18.4% during the forecast period (2015–2020). A biochip is an assembly of miniaturized test sites arranged on a solid substrate that permits many tests to be performed at the same time in order to achieve higher throughput.
 
 In this report, the biochips market is segmented on the basis of type, application, fabrication technology, end user, and region. Based on type, the market is segmented into DNA chips, lab-on-a-chip, protein chips, and other arrays. The other arrays segment includes cell arrays and tissue arrays.
 
 Based on end users, the biochips market is categorized into four major segments, namely, hospitals & diagnostic centers, biotechnology & pharmaceutical companies, academic & research institutes, and other end users (blood banks, CROs, forensic labs, point-of-care settings, home health agencies, nursing homes, and local public health laboratories). Similarly, based on fabrication technology, the biochips market is segmented into microarrays and microfluidics.
 
 Increasing adoption of personalized medicine, growing applications of biochips, and technological advancements are the major drivers for the biochips market. However, unclear regulatory guidelines, high instrumentation costs, and absolute quantification of specific mRNA may restrain the market growth to a certain extent. On the other hand, developing countries are expected to offer significant growth opportunities for players operating in the biochips market.
 
 PerkinElmer Inc. (U.S.), Fluidigm Corporation (U.S.), Illumina, Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.), Cepheid Inc. (U.S.), and Thermo Fisher Scientific, Inc. (U.S.) are the major players in the biochips market.
 
 Reasons to buy this report:
 From an insight perspective, this research report focuses on various levels of analysis—industry analysis (industry trends) and company profiles, which together comprise and discuss the basic views on the competitive landscape; emerging and high-growth segments of the biochips market; high-growth regions; and market drivers, restraints, and opportunities.
 
 The report provides insights on the following pointers:
 

 • Market Penetration: Comprehensive information on products offered by the top players in the global biochips market
 
 • Product Development/Innovation: Detailed insights on the upcoming technologies, research & development activities, and new product launches in the biochips market
 
 • Market Development: Comprehensive information about lucrative emerging markets—the report analyzes the markets for biochips across various regions
 
 • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the global biochips market
 
 • Competitive Assessment: In-depth assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the biochips market
 

 1 INTRODUCTION 15
 1.1 OBJECTIVES OF THE STUDY 15
 1.2 MARKET DEFINITION 16
 1.3 MARKETS SCOPE 16
 1.3.1 MARKETS COVERED 16
 1.3.2 YEARS CONSIDERED FOR THE STUDY 17
 1.4 CURRENCY 17
 1.5 LIMITATIONS 17
 1.6 STAKEHOLDERS 18
 2 RESEARCH METHODOLOGY 19
 2.1 MARKET SIZE ESTIMATION 20
 2.2 MARKET BREAKDOWN AND DATA TRIANGULATION 23
 2.2.1 KEY DATA FROM SECONDARY SOURCES 24
 2.2.2 KEY DATA FROM PRIMARY SOURCES 25
 2.2.3 KEY INDUSTRY INSIGHTS 26
 2.2.4 ASSUMPTIONS 27
 3 EXECUTIVE SUMMARY 28
 4 PREMIUM INSIGHTS 33
 4.1 BIOCHIPS MARKET OVERVIEW 33
 4.2 BIOCHIPS MARKET: BY APPLICATION AND END USER 34
 4.3 BIOCHIPS MARKET: GEOGRAPHIC SNAPSHOT 35
 4.4 BIOCHIPS MARKET: BY TYPE 36
 4.5 BIOCHIPS MARKET: BY END USER 37
 4.6 BIOCHIPS MARKET: BY FABRICATION TECHNOLOGY 38
 5 MARKET OVERVIEW 39
 5.1 INTRODUCTION 40
 5.2 MARKET SEGMENTATION 40
 5.2.1 BY TYPE AND APPLICATION 40
 5.2.2 BY FABRICATION TECHNOLOGY 41
 5.2.3 BY END USER 41
  
 5.3 MARKET DYNAMICS 42
 5.3.1 DRIVERS 43
 5.3.1.1 Increasing adoption of personalized medicine 43
 5.3.1.2 Growing applications of biochips 44
 5.3.1.3 Technological advancements 45
 5.3.2 RESTRAINTS 46
 5.3.2.1 Unclear regulatory guidelines 46
 5.3.2.2 High instrumentation costs 46
 5.3.2.3 Absolute quantification of specific mRNA expressions 46
 5.3.3 OPPORTUNITIES 47
 5.3.3.1 Significant growth prospects in developing countries 47
 5.3.3.2 Biochip technology, a safe and economical alternative to animal testing 48
 5.3.4 CHALLENGES 49
 5.3.4.1 Complexity of biological systems 49
 6 BIOCHIPS MARKET, BY TYPE 50
 6.1 INTRODUCTION 51
 6.2 DNA CHIPS 52
 6.2.1 DNA CHIPS MARKET, BY APPLICATION 54
 6.2.1.1 Gene expression 55
 6.2.1.2 SNP Genotyping 56
 6.2.1.3 Cancer Diagnosis & Treatment 58
 6.2.1.4 Genomics 60
 6.2.1.5 Drug Discovery 61
 6.2.1.6 Agricultural Biotechnology 63
 6.2.1.7 Other DNA Chip Applications 64
 6.3 LAB-ON-A-CHIP 65
 6.3.1 LAB-ON-A-CHIP MARKET, BY APPLICATION 66
 6.3.1.1 Clinical Diagnostics 67
 6.3.1.2 Genomics 69
 6.3.1.3 IVD & POC 70
 6.3.1.4 Proteomics 72
 6.3.1.5 Drug Discovery 73
 6.3.1.6 Other LOAC Applications Market 75
 6.4 PROTEIN CHIPS 75
 6.4.1 PROTEIN CHIPS MARKET, BY APPLICATIONS 77
 6.4.1.1 Proteomics 77
 6.4.1.2 Expression Profiling 79
 6.4.1.3 Diagnostics 80
 6.4.1.4 High-throughput Screening 81
 6.4.1.5 Drug Discovery 83
 6.4.1.6 Other Applications 84
 6.5 OTHER ARRAYS 85
 6.5.1 CELL ARRAYS 87
 6.5.2 TISSUE ARRAYS 88
 7 BIOCHIPS MARKET, BY FABRICATION TECHNOLOGY 89
 7.1 INTRODUCTION 90
 7.2 MICROARRAYS 91
 7.3 MICROFLUIDICS 92
 8 BIOCHIPS MARKET, BY END USER 95
 8.1 INTRODUCTION 96
 8.2 BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES 97
 8.3 HOSPITALS AND DIAGNOSTICS CENTERS 98
 8.4 ACADEMIC & RESEARCH INSTITUTES 99
 8.5 OTHERS 101
 9 BIOCHIPS MARKET, BY REGION 103
 9.1 INTRODUCTION 104
 9.2 NORTH AMERICA 106
 9.3 EUROPE 113
 9.4 ASIA-PACIFIC 118
 9.5 REST OF THE WORLD (ROW) 125
 10 COMPETITIVE LANDSCAPE 130
 10.1 OVERVIEW 131
 10.2 COMPETITIVE SITUATION AND TRENDS 132
 10.2.1 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS 133
 10.2.2 ACQUISITIONS 134
 10.2.3 PRODUCT LAUNCHES AND ENHANCEMENTS 135
 10.2.4 EXPANSIONS 136
 10.2.5 OTHER DEVELOPMENTS 136
 11 COMPANY PROFILES 138
 (Overview, Financial*, Products & Services, Strategy, and Developments)
 11.1 INTRODUCTION 138
 11.2 ABBOTT LABORATORIES 139
 11.3 AGILENT TECHNOLOGIES, INC. 141
 11.4 PERKINELMER, INC. 144
 11.6 FLUIDIGM CORPORATION 147
 11.7 ILLUMINA, INC. 149
 11.8 GE HEALTHCARE 151
 11.9 BIO-RAD LABORATORIES INC. 153
 11.10 CEPHEID INC. 155
 11.12 THERMO FISHER SCIENTIFIC, INC. 157
 11.13 ROCHE DIAGNOSTICS 160
 *Details might not be captured in case of unlisted companies.
 12 APPENDIX 162
 12.1 INSIGHTS OF INDUSTRY EXPERTS 162
 12.2 DISCUSSION GUIDE 163
 12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 166
 12.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 168
 12.5 AVAILABLE CUSTOMIZATIONS 169
 12.6 RELATED REPORTS 170


List Of Tables

 TABLE 1 INCREASING ADOPTION OF PERSONALIZED MEDICINE, A KEY DRIVER FOR
 THE GROWTH OF THE BIOCHIPS MARKET 45
 TABLE 2 REGULATORY HURDLES TO LIMIT MARKET GROWTH DURING
 THE FORECAST PERIOD 47
 TABLE 3 LUCRATIVE OPPORTUNITIES IN DEVELOPING COUNTRIES MAY
 BOOST MARKET GROWTH 49
 TABLE 4 COMPLEXITY OF BIOLOGICAL SYSTEMS MAY HAMPER THE GROWTH OF
 THE MARKET 49
 TABLE 5 BIOCHIPS MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION) 51
 TABLE 6 DNA CHIPS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION) 53
 TABLE 7 DNA CHIPS MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION) 54
 TABLE 8 GENE EXPRESSION MARKET SIZE, BY REGION, 2013–2020 (USD MILLION) 56
 TABLE 9 SNP GENOTYPING MARKET SIZE, BY REGION, 2013–2020 (USD MILLION) 57
 TABLE 10 CANCER DIAGNOSIS AND TREATMENT MARKET SIZE, BY REGION,
 2013–2020 (USD MILLION) 59
 TABLE 11 GENOMICS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION) 61
 TABLE 12 DRUG DISCOVERY MARKET SIZE, BY REGION, 2013–2020 (USD MILLION) 62
 TABLE 13 AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY REGION,
 2013–2020 (USD MILLION) 64
 TABLE 14 OTHER DNA CHIP APPLICATIONS MARKET SIZE, BY REGION,
 2013–2020 (USD MILLION) 64
 TABLE 15 LAB-ON-A-CHIP MARKET SIZE, BY REGION, 2013–2020 (USD MILLION) 65
 TABLE 16 LAB-ON-A-CHIP MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION) 67
 TABLE 17 CLINICAL DIAGNOSTICS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION) 68
 TABLE 18 GENOMICS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION) 70
 TABLE 19 IVD AND POC MARKET SIZE, BY REGION, 2013–2020 (USD MILLION) 71
 TABLE 20 PROTEOMICS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION) 73
 TABLE 21 DRUG DISCOVERY MARKET SIZE, BY REGION, 2013–2020 (USD MILLION) 74
 TABLE 22 OTHER LOC SYSTEMS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION) 75
 TABLE 23 PROTEIN CHIPS MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION) 76
 TABLE 24 PROTEIN CHIPS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION) 77
 TABLE 25 PROTEOMICS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION) 78
 TABLE 26 EXPRESSION PROFILING MARKET SIZE, BY REGION, 2013–2020 (USD MILLION) 79
 TABLE 27 DIAGNOSTICS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION) 81
 TABLE 28 HIGH-THROUGHPUT SCREENING MARKET SIZE, BY REGION,
 2013–2020 (USD MILLION) 82
 TABLE 29 DRUG DISCOVERY MARKET SIZE, BY REGION, 2013–2020 (USD MILLION) 84
 TABLE 30 OTHER PROTEIN MICROARRAY APPLICATIONS MARKET SIZE, BY REGION,
 2013–2020 (USD MILLION) 85
 TABLE 31 OTHER ARRAYS MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION) 86
 TABLE 32 OTHER ARRAYS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION) 87
 TABLE 33 CELL ARRAYS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION) 87
 TABLE 34 TISSUE ARRAYS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION) 88
 TABLE 35 BIOCHIP MARKET SIZE, BY FABRICATION TECHNOLOGY, 2013–2020 (USD MILLION) 91
 TABLE 36 MICROARRAYS IN BIOCHIPS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 92
 TABLE 37 MICROFLUIDICS IN BIOCHIPS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 94
 TABLE 38 BIOCHIPS MARKET SIZE, BY END USER, 2013–2020 (USD MILLION) 96
 TABLE 39 BIOCHIPS MARKET SIZE FOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES,
 BY REGION, 2013–2020 (USD MILLION) 98
 TABLE 40 BIOCHIPS MARKET SIZE FOR HOSPITALS & DIAGNOSTIC CENTERS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION) 99
 TABLE 41 BIOCHIPS MARKET SIZE FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION,
 2013–2020 (USD MILLION) 100
 TABLE 42 BIOCHIPS MARKET SIZE FOR OTHER END USERS, BY REGION,
 2013–2020 (USD MILLION) 102
 TABLE 43 BIOCHIPS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION) 106
 TABLE 44 NORTH AMERICA: BIOCHIPS MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION) 108
 TABLE 45 NORTH AMERICA: OTHER BIOCHIPS MARKET SIZE, BY TYPE,
 2013–2020 (USD MILLION) 108
 TABLE 46 NORTH AMERICA: DNA CHIPS MARKET SIZE, BY APPLICATION,
 2013–2020 (USD MILLION) 109
 TABLE 47 NORTH AMERICA: LAB-ON-CHIP MARKET SIZE, BY APPLICATION,
 2013–2020 (USD MILLION) 110
 TABLE 48 NORTH AMERICA: PROTEIN CHIPS MARKET SIZE, BY APPLICATION,
 2013–2020 (USD MILLION) 111
 TABLE 49 NORTH AMERICA: BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY,
 2013–2020 (USD MILLION) 111
 TABLE 50 NORTH AMERICA: BIOCHIPS MARKET SIZE, BY END USER,
 2013–2020 (USD MILLION) 112
 TABLE 51 EUROPE: BIOCHIPS MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION) 114
 TABLE 52 EUROPE: OTHER BIOCHIPS MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION) 114
 TABLE 53 EUROPE: DNA CHIPS MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION) 115
 TABLE 54 EUROPE: LAB-ON-CHIP MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION) 116
 TABLE 55 EUROPE: PROTEIN CHIPS MARKET SIZE, BY APPLICATION,
 2013–2020 (USD MILLION) 116
 TABLE 56 EUROPE: BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY,
 2013–2020 (USD MILLION) 117
 TABLE 57 EUROPE: BIOCHIPS MARKET SIZE, BY END USER, 2013–2020 (USD MILLION) 118
 TABLE 58 ASIA-PACIFIC: BIOCHIPS MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION) 120
 TABLE 59 ASIA-PACIFIC: OTHER BIOCHIPS MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION) 120
 TABLE 60 ASIA-PACIFIC: DNA CHIPS MARKET SIZE, BY APPLICATION,
 2013–2020 (USD MILLION) 121
 TABLE 61 ASIA-PACIFIC: LAB-ON-CHIP MARKET SIZE, BY APPLICATION,
 2013–2020 (USD MILLION) 122
 TABLE 62 ASIA-PACIFIC: PROTEIN CHIPS MARKET SIZE, BY APPLICATION,
 2013–2020 (USD MILLION) 123
 TABLE 63 ASIA-PACIFIC: BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY,
 2013–2020 (USD MILLION) 123
 TABLE 64 ASIA-PACIFIC: BIOCHIPS MARKET SIZE, BY END USER, 2013–2020 (USD MILLION) 124
 TABLE 65 ROW: BIOCHIPS MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION) 126
 TABLE 66 ROW: OTHER BIOCHIPS MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION) 126
 TABLE 67 ROW: DNA CHIPS MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION) 127
 TABLE 68 ROW: LAB-ON-CHIP MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION) 127
 TABLE 69 ROW: PROTEIN CHIPS MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION) 128
 TABLE 70 ROW: BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY,
 2013–2020 (USD MILLION) 128
 TABLE 71 ROW: BIOCHIPS MARKET SIZE, BY END USER, 2013–2020 (USD MILLION) 129
 TABLE 72 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2013–2016 133
 TABLE 73 ACQUISITIONS, 2013-2015 134
 TABLE 74 PRODUCT LAUNCHES AND ENHANCEMENTS, 2013–2015 135
 TABLE 75 EXPANSIONS, 2013–2015 136
 TABLE 76 OTHER DEVELOPMENTS, 2013–2015 136


List Of Figures

 FIGURE 1 RESEARCH DESIGN 19
 FIGURE 2 MARKET SIZE ESTIMATION AND DATA TRIANGULATION 21
 FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND COUNTRY 22
 FIGURE 4 BIOCHIPS MARKET SNAPSHOT, 2015 VS. 2020 28
 FIGURE 5 DNA CHIPS SEGMENT WILL CONTINUE TO DOMINATE THE BIOCHIPS MARKET IN
 2020 29
 FIGURE 6 MICROFLUIDICS SEGMENT TO WITNESS THE HIGHEST GROWTH RATE IN
 THE FORECAST PERIOD 30
 FIGURE 7 HOSPITALS AND DIAGNOSTICS CENTERS SEGMENT DOMINATED
 THE BIOCHIPS END-USER MARKET IN 2015 31
 FIGURE 8 GEOGRAPHICAL SNAPSHOT OF THE BIOCHIPS MARKET, 2015 32
 FIGURE 9 INCREASED ADOPTION OF PERSONALISED MEDICINE TO DRIVE
 THE BIOCHIPS MARKET GROWTH DURING THE FORECAST PERIOD 33
 FIGURE 10 DNA CHIPS TO DOMINATE THE GLOBAL BIOCHIPS MARKET DURING
 THE FORECAST PERIOD 34
 FIGURE 11 ASIA-PACIFIC TO REGISTER HIGHEST GROWTH FROM 2015 TO 2020 35
 FIGURE 12 LAB-ON-A-CHIP SEGMENT TO GROW AT THE HIGHEST RATE FROM 2015 TO 2020 36
 FIGURE 13 HOSPITALS & DIAGNOSTIC CENTERS TO DOMINATE THE BIOCHIPS
 END-USER MARKET IN 2015 37
 FIGURE 14 HIGH GROWTH POTENTIAL IN THE MICROFLUIDICS FABRICATION TECHNOLOGY MARKET 38
 FIGURE 15 BIOCHIPS MARKET SEGMENTATION, BY TYPE AND APPLICATION 40
 FIGURE 16 BIOCHIPS MARKET SEGMENTATION, BY FABRICATION TECHNOLOGY 41
 FIGURE 17 BIOCHIPS MARKET SEGMENTATION, BY END USER 41
 FIGURE 18 BIOCHIPS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES 42
 FIGURE 19 ONCOLOGY TREATMENT OPTIONS MARKET SHARE, 2003 VS. 2013 43
 FIGURE 20 LOCAL VS. MULTINATIONAL CLINICAL STUDIES, 2015 48
 FIGURE 21 DNA BIOCHIPS ACCOUNTED FOR THE LARGEST SHARE OF THE OVERALL BIOCHIPS MARKET, BY TYPE, IN 2015 51
 FIGURE 22 ASIA-PACIFIC TO GROW AT THE HIGHEST RATE IN THE OVERALL
 DNA CHIPS MARKET, BY REGION, DURING THE FORECAST PERIOD 52
 FIGURE 23 CANCER DIAGNOSIS AND TREATMENT ACCOUNTED FOR
 THE LARGEST SHARE OF DNA CHIPS MARKET, BY APPLICATION, IN 2015 54
 FIGURE 24 ASIA-PACIFIC IS EXPECTED TO REGISTER THE HIGHEST GROWTH RATE IN
 THE GENE EXPRESSION MARKET, BY REGION, DURING THE FORECAST PERIOD 55
 FIGURE 25 NORTH AMERICA ACCOUNTED FOR THE LARGEST SHARE OF THE
 SNP GENOTYPING MARKET DURING THE FORECAST PERIOD 57
 FIGURE 26 ASIA-PACIFIC IS EXPECTED TO ACCOUNT FOR HIGHEST GROWTH RATE OF
 THE CANCER DIAGNOSIS AND TREATMENT MARKET, BY REGION, DURING
 THE FORECAST PERIOD 58
 FIGURE 27 NORTH AMERICA ACCOUNTED FOR THE LARGEST SHARE OF
 THE GENOMICS MARKET, BY TYPE, IN 2015 60
 FIGURE 28 ASIA-PACIFIC TO GROW AT THE HIGHEST RATE IN THE DRUG DISCOVERY MARKET,
 BY REGION, DURING THE FORECAST PERIOD 62
 FIGURE 29 NORTH AMERICA ACCOUNTED FOR THE LARGEST SHARE OF THE AGRICULTURE BIOTECHNOLOGY MARKET, BY APPLICATION, DURING THE FORECAST PERIOD 63
 FIGURE 30 CLINICAL DIAGNOSTICS ACCOUNTED FOR THE LARGEST SHARE OF
 THE LAB-ON-A-CHIP MARKET, BY APPLICATION, IN 2015 66
 FIGURE 31 ASIA-PACIFIC TO GROW AT THE HIGHEST RATE IN THE CLINICAL
 DIAGNOSTICS MARKET, BY REGION, DURING THE FORECAST PERIOD 68
 FIGURE 32 NORTH AMERICA ACCOUNTED FOR THE LARGEST SHARE OF
 THE GENOMICS MARKET, BY REGION, IN 2015 69
 FIGURE 33 ASIA-PACIFIC TO REGISTER HIGHEST GROWTH IN THE IVD AND POC MARKET,
 BY REGION DURING THE FORECAST PERIOD 71
 FIGURE 34 NORTH AMERICA ACCOUNTED FOR THE LARGEST SHARE OF
 THE PROTEOMICS MARKET, BY REGION, IN 2015 72
 FIGURE 35 ASIA-PACIFIC TO GROW AT THE HIGHEST RATE IN THE DRUG
 DISCOVERY MARKET, BY REGION DURING THE FORECAST PERIOD 74
 FIGURE 36 PROTEOMICS ACCOUNTED FOR THE LARGEST SHARE OF THE
 PROTEIN CHIPS MARKET, BY APPLICATION, IN 2015 76
 FIGURE 37 NORTH AMERICA ACCOUNTED FOR THE LARGEST SHARE OF
 THE PROTEOMICS MARKET, BY REGION, IN 2015 78
 FIGURE 38 ASIA-PACIFIC TO GROW AT THE HIGHEST RATE IN
 THE EXPRESSION PROFILING MARKET DURING THE FORECAST PERIOD 79
 FIGURE 39 NORTH AMERICA ACCOUNTED FOR THE LARGEST SHARE OF
 THE DIAGNOSTICS MARKET, BY REGION, IN 2015 80
 FIGURE 40 ASIA-PACIFIC MARKET WILL REGISTER THE FASTEST GROWTH IN
 THE HTS MARKET DURING THE FORECAST PERIOD 82
 FIGURE 41 NORTH AMERICA ACCOUNTED FOR THE LARGEST SHARE OF
 THE DRUG DISCOVERY MARKET, BY REGION, IN 2015 83
 FIGURE 42 TISSUE ARRAYS ACCOUNTED FOR THE LARGEST SHARE OF
 THE OVERALL OTHER ARRAYS MARKET, BY TYPE, IN 2015 85
 FIGURE 43 ASIA-PACIFIC TO GROW AT THE HIGHEST RATE IN
 THE OTHER ARRAYS MARKET DURING THE FORECAST PERIOD 86
 FIGURE 44 MICROARRAYS WILL CONTINUE TO DOMINATE THE BIOCHIPS MARKET IN 2020 90
 FIGURE 45 NORTH AMERICA ACCOUNTED FOR THE LARGEST SHARE OF
 MICROARRAYS MARKET IN 2015 92
 FIGURE 46 ASIA-PACIFIC TO WITNESS HIGHEST GROWTH IN MICROFLUIDICS IN BIOCHIPS MARKET 93
 FIGURE 47 HOSPITALS AND DIAGNOSTIC CENTERS ARE THE MAJOR END USERS OF
 THE BIOCHIPS MARKET DURING THE FORECAST PERIOD 96
 FIGURE 48 NORTH AMERICA WILL CONTINUE TO DOMINATE THE BIOCHIPS MARKET FOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES DURING THE FORECAST PERIOD 97
 FIGURE 49 ASIA-PACIFIC OFFERS LUCRATIVE GROWTH OPPORTUNITIES FOR
 BIOCHIPS MARKET FOR HOSPITALS AND DIAGNOSTICS CENTERS DURING
 THE FORECAST PERIOD 99
 FIGURE 50 NORTH AMERICA ACCOUNTED FOR THE LARGEST SHARE OF
 THE OTHER END USERS MARKET IN 2015 101
 FIGURE 51 GEOGRAPHIC SNAPSHOT: ASIA-PACIFIC WILL BE THE FASTEST-GROWING
 REGION IN THE BIOCHIPS MARKET BY 2020 104
 FIGURE 52 ASIA-PACIFIC MARKET FOR BIOCHIPS SHOWS SIGNIFICANT GROWTH OPPORTUNITIES 105
 FIGURE 53 NORTH AMERICA WILL CONTINUE TO LEAD THE GLOBAL BIOCHIPS
 MARKET DURING THE FORECAST PERIOD 105
 FIGURE 54 NORTH AMERICA: BIOCHIPS MARKET SNAPSHOT 2015-2020 107
 FIGURE 55 GENE EXPRESSION SEGMENT TO SHOW HIGHEST GROWTH IN
 THE NORTH AMERICAN DNA CHIPS MARKET DURING THE FORECAST PERIOD 109
 FIGURE 56 PROTEOMICS WILL CONTINUE TO LEAD THE NORTH AMERICAN PROTEIN
 CHIPS MARKET DURING THE FORECAST PERIOD 110
 FIGURE 57 HOSPITAL AND DIAGNOSTICS CENTERS SEGMENT TO GROW AT
 THE HIGHEST CAGR DURING THE FORECAST PERIOD 112
 FIGURE 58 DNA CHIPS WILL CONTINUE TO DOMINATE THE EUROPEAN BIOCHIPS
 MARKET DURING THE FORECAST PERIOD 113
 FIGURE 59 GENE EXPRESSION APPLICATION SEGMENT OF THE EUROPEAN
 DNA CHIPS MARKET IS EXPECTED TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD 115
 FIGURE 60 HOSPITAL AND DIAGNOSTICS CENTERS END-USER SEGMENT WILL
 CONTINUE TO DOMINATE THE EUROPEAN MARKET DURING THE FORECAST PERIOD 117
 FIGURE 61 ASIA-PACIFIC BIOCHIPS MARKET SNAPSHOT 2015-2020 119
 FIGURE 62 GENE EXPRESSION SEGMENT WILL CONTINUE TO LEAD THE ASIA-PACIFIC
 DNA CHIPS MARKET DURING THE FORECAST PERIOD 121
 FIGURE 63 PROTEOMICS HOLDS HIGHEST SHARE IN THE ASIA-PACIFIC PROTEIN
 CHIPS MARKET IN 2015 122
 FIGURE 64 HOSPITAL AND DIAGNOSTICS CENTERS SEGMENT TO GROW AT
 THE HIGHEST CAGR DURING THE FORECAST PERIOD 124
 FIGURE 65 DNA CHIPS WILL CONTINUE TO HOLD THE HIGHEST SHARE IN
 THE ROW BIOCHIPS MARKET DURING THE FORECAST PERIOD 125
 FIGURE 66 HOSPITAL AND DIAGNOSTICS CENTERS WILL CONTINUE TO LEAD
 THE GLOBAL BIOCHIPS MARKET DURING THE FORECAST PERIOD 129
 FIGURE 67 ACQUISITIONS & AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS WERE
 THE KEY GROWTH STRATEGIES ADOPTED BY MARKET PLAYERS BETWEEN
 2013-2016 131
 FIGURE 68 ACQUISITIONS & AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS—
 KEY GROWTH STRATEGIES ADOPTED BY PLAYERS IN BIOCHIPS MARKET 132
 FIGURE 69 GEOGRAPHIC REVENUE MIX OF THE TOP 5 MARKET PLAYERS 138
 


Global and USA Biochips Market Report 2016

This report studies sales (consumption) of Biochips in Global and USA market, focuses on top players, with sales, price, revenue, gross margin and market share for each player, coveringGE Healthcare

USD 3800View Report

Global Protein Biochips Sales Market Report 2016

Notes:Sales, means the sales volume of Protein BiochipsRevenue, means the sales value of Protein BiochipsThis report studies sales (consumption) of Protein Biochips in Global market, especially in USA, China, Europe,

USD 4000View Report

Global Protein Biochips Market Research Report 2016

Notes:Production, means the output of Protein BiochipsRevenue, means the sales value of Protein BiochipsThis report studies Protein Biochips in Global market, especially in North America, Europe, China, Japan, Southeast Asia

USD 2900View Report

Syringes Market by Usability - Global Forecast to 2021

Syringes Market by Usability (Sterilizable/reusable (hypodermic, oral) & Disposable Syringes (conventional, safety, prefilled)), Material (Glass & Plastic Syringes), Type (General & Specialized Syringes (insulin, tuberculin) - Global Forecast to 2021

USD 5650View Report

GFRP Composites Market By Resin Type - Global Forecast To 2026

GFRP Composites Market By Resin Type (Polyester, Vinyl Ester, Epoxy, Polyurethane), Manufacturing Process (Manual Process, Compression Molding, Continuous Process, Injection Molding), Application (Wind Energy, Transportation, Marine, Pipe & Tanks) By

USD 5650View Report

India Television Market By Type (LED, OLED, LCD, Plasma), By Resolution (High Definition (HD, Full High Definition (FHD) and Ultra-High Definition (UHD)), Forecast & Opportunities, 2021

From luxury to necessity, television has now become an integral part of the daily life. Over the period of time, the countrys television market has seen numerous technological advancements

USD 2500View Report

Fill The Form For Sample Request
Name*
Email*
Mobile No.*
LandLine No.
If you want to purchase particular section from this report then kindly contact us at contact@aarkstore.com.

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    $ 4650
  • Multi User Licence    $ 5650
  • Corporate Licence    $ 7150
  • Enterprise Wide Licence    $ 9000
$ 4650

Reports Details

Published Date : May 2016
No. of Pages :171
Country :Global
Category :Chemicals
Publisher :MarketsandMarkets
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

payment